Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Brunswick (BC)

Brunswick Q4 sales fall 14% to $1.36 billion; 2024 adjusted EPS guided $7.00-$8.00

Negative Impact 3 of 5 earnings Written later

Brunswick reported fourth-quarter 2023 net sales of $1,361.9 million, down 14% from a year earlier, and GAAP diluted EPS of $1.03 versus $1.93. For full-year 2023, GAAP diluted EPS fell 32.3% to $6.13 and adjusted diluted EPS fell 12.3% to $8.80. The company guided 2024 net sales of $6.0 billion to $6.2 billion and adjusted diluted EPS of $7.00 to $8.00, and its board increased the share repurchase authorization to over $500 million.

Key points

  • Q4 2023 net sales were $1,361.9 million, down from $1,582.7 million; GAAP diluted EPS was $1.03 versus $1.93, and adjusted EPS was $1.45 versus $1.99.
  • Full-year 2023 net sales were $6.4 billion, down 6.0%; GAAP diluted EPS was $6.13 versus $9.06 in 2022.
  • 2024 guidance: net sales of $6.0 billion to $6.2 billion, adjusted diluted EPS of $7.00 to $8.00, and free cash flow in excess of $350 million.
  • Board increased the share repurchase authorization; over $500 million is now approved for repurchases.

The filing

CompanyBrunswick (BC)
Form8-K, current report
Filed with the SECFeb 1, 2024, 6:16 AM ET
Accession number0000014930-24-000007

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 01, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.